J Korean Med Assoc.  2010 Jul;53(7):623-629. 10.5124/jkma.2010.53.7.623.

Pharmacologic Treatment of Acne

• Suh DH

• KMID: 2188338
• DOI: http://doi.org/10.5124/jkma.2010.53.7.623

Abstract

Acne is one of the most common skin diseases. It usually occurs during adolescence, but can persist into middle age. The most deleterious form can result in permanent scarring on the face, chest, and back. The pathogenesis of acne is thought to be multifactorial. There are four most significant pathogenic factors of acne: Androgen-stimulated production of sebum, hyperkeratinization and obstruction of sebaceous follicles, proliferation of Propionibacterium acnes and inflammation. Therefore, pharmacologic treatment of acne should be focused on at least one of these main causative factors. The ultimate goal of treatment is to address as many of the pathogenic factors of acne as possible while minimizing side effects. Topical retinoids correct abnormal keratinization, but it should be applied cautiously because of irritation. Benzoyl peroxide is an effective bactericidal agent against P. acnes. Main topical antibiotics are erythromycin and clindamycin. Recently, fixed combination topical products have been highlighted. Use of Systemic antibiotics, including tetracyclines and macrolides rapidly improves inflammatory acne lesions. Oral isotretinoin is effective against all of the pathogenic features of acne but is contraindicated in pregnant women and has been associated with elevations in triglyceride levels, cheilitis and dry skin. Hormonal therapy has been found to improve acne in some women and should be considered for appropriate candidates. Because acne is a complex multifactorial disorder, combination treatment may be required to target its various pathogenic factors. Combination treatments also offer the most improvement over the shortest time. This review provides a general overview of pharmacologic treatment of acne.

Keyword

Acne; Antibacterial agent; Comedolytic agent; Sebaceous gland

MeSH Terms

Acne Vulgaris
Adolescent
Anti-Bacterial Agents
Benzoyl Peroxide
Cheilitis
Cicatrix
Clindamycin
Erythromycin
Female
Humans
Inflammation
Isotretinoin
Keratins
Macrolides
Middle Aged
Pregnant Women
Propionibacterium acnes
Retinoids
Sebaceous Glands
Sebum
Skin
Skin Diseases
Tetracyclines
Thorax
Anti-Bacterial Agents
Benzoyl Peroxide
Clindamycin
Erythromycin
Isotretinoin
Keratins
Macrolides
Retinoids
Tetracyclines

Reference

1. Jung JY, Kwon HH, Yeom KB, Yoon MY, Suh DH. Clinical and histological evaluation of 1% nadifloxacin cream for the treatment of Korean acne vulgaris patients. Clin Exp Dermatol. 2010. in press.

2. Lee DH, Choi YS, Min SU, Yoon MY, Suh DH. Comparison of a 585-nm pulsed dye laser and a 1064-nm Nd: YAG laser for the treatment of acne scars: A randomized split-face clinical study. J Am Acad Dermatol. 2009. 60:801–807.

3. Suh DH, Shin JW, Min SU, Lee DH, Yoon MY, Kim NI, Kye YC, Lee ES, Ro YS, Kim KJ. Treatment-seeking behaviors and related epidemiological features in Korean acne patients. J Korean Med Sci. 2008. 23:969–974.

4. Gollnick H, Cunliffe W, Berson D, Dreno B, Finlay A, Leyden JJ, Shalita AR, Thiboutot D. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2003. 49:S1–S37.

5. Thiboutot D, Gollnick H, Bettoli V, Dréno B, Kang S, Leyden JJ, Shalita AR, Lozada VT, Berson D, Finlay A, Goh CL, Herane MI, Kaminsky A, Kubba R, Layton A, Miyachi Y, Perez M, Martin JP, Ramos-E-Silva M, See JA, Shear N, Wolf J Jr. New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group. J Am Acad Dermatol. 2009. 60:S1–S50.